This is a demo store. No orders will be fulfilled.

tirabrutinib(ONO-4059) hydrochloride - 10mM in DMSO, high purity , CAS No.1439901-97-9

    Grade & Purity:
  • 10mM in DMSO
In stock
Item Number
T421616
Grouped product items
SKU Size
Availability
Price Qty
T421616-1ml
1ml
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$241.90

BTK Inhibitors

Basic Description

Synonyms 1439901-97-9 | Tirabrutinib hydrochloride | ONO-4059 Hydrochloride | Tirabrutinib HCl | Tirabrutinib (hydrochloride) | ONO-4059 (hydrochloride) | ONO4059 hydrochloride | GS-4059 hydrochloride | Ono-4059(HCl salt) | U374135N48 | 6-amino-9-[(3R)-1-but-2-ynoylpyrrolidin-3-yl]-7
Specifications & Purity 10mM in DMSO
Biochemical and Physiological Mechanisms Tirabrutinib Hydrochloride (ONO-4059, GS-4059) is highly potent and selective BTK inhibitor with an IC50 of 2.2 nM.
Storage Temp Store at -80°C
Shipped In
Ice chest + Ice pads
This product requires cold chain shipping. Ground and other economy services are not available.
Product Description

Information

tirabrutinib(ONO-4059) hydrochloride Tirabrutinib Hydrochloride (ONO-4059, GS-4059) is highly potent and selective BTK inhibitor with an IC50 of 2.2 nM.

Targets

BTK 2.2 nM

In vitro

ONO-4059 covalently binds to BTK, and reversibly blocks BCR signaling and B-cell proliferation and activation. It has greater selectivity for BTK than Lck, Fyn, LynA and ONO/GS-4059 only inhibits anti-IgM-induced B-cell activation in a concentration-dependent manner but not inhibit anti-CD3/CD28-induced activation of T-lymphocytes from human PBMCs. ONO/GS-4059 inhibits cell proliferation in some malignant B-cell lines but also induces classical apoptosis at nanomolar concentration in the activated-B cell (ABC) DLBCL cell line, TMD8.

In vivo

ONO-4059 demonstrates therapeutic efficacy in a mouse CIA model by suppressing generation of inflammatory chemokines and cytokines including IL-6, IL-8, and TNFα by monocytes, and accompanied by regression of cartilage erosion, bone damage, and pannus formation. In pre-clinical models, and in the clinic in both CLL and NHL patients, It exerts its anti-tumour activity, with a favourable safety profile along with promising efficacy over a long duration.

Cell Research(from reference)

Cell lines:DLBCL cell lines TMD8 cells 

Concentrations:320 nM 

Incubation Time:48 h 

Taxonomic Classification

Taxonomy Tree

Kingdom Organic compounds
Superclass Benzenoids
Class Benzene and substituted derivatives
Subclass Diphenylethers
Intermediate Tree Nodes Not available
Direct Parent Diphenylethers
Alternative Parents Diarylethers  Phenylimidazoles  Purinones  6-aminopurines  Phenoxy compounds  Phenol ethers  N-acylpyrrolidines  Aminopyrimidines and derivatives  Imidolactams  N-substituted imidazoles  Heteroaromatic compounds  Tertiary carboxylic acid amides  Ureas  Amino acids and derivatives  Azacyclic compounds  Hydrochlorides  Hydrocarbon derivatives  Carbonyl compounds  Primary amines  Organic oxides  
Molecular Framework Aromatic heteropolycyclic compounds
Substituents Diphenylether - Diaryl ether - 1-phenylimidazole - 6-aminopurine - Purinone - Imidazopyrimidine - Purine - Phenoxy compound - N-acylpyrrolidine - Phenol ether - Aminopyrimidine - Imidolactam - Pyrimidine - N-substituted imidazole - Azole - Heteroaromatic compound - Imidazole - Tertiary carboxylic acid amide - Pyrrolidine - Amino acid or derivatives - Carboxamide group - Urea - Organoheterocyclic compound - Ether - Azacycle - Carboxylic acid derivative - Primary amine - Organic oxide - Hydrochloride - Organic oxygen compound - Carbonyl group - Hydrocarbon derivative - Organic nitrogen compound - Organonitrogen compound - Organooxygen compound - Amine - Aromatic heteropolycyclic compound
Description This compound belongs to the class of organic compounds known as diphenylethers. These are aromatic compounds containing two benzene rings linked to each other through an ether group.
External Descriptors Not available

Product Properties

ALogP 3.706
HBD Count 1
Rotatable Bond 5

Names and Identifiers

IUPAC Name 6-amino-9-[(3R)-1-but-2-ynoylpyrrolidin-3-yl]-7-(4-phenoxyphenyl)purin-8-one;hydrochloride
INCHI InChI=1S/C25H22N6O3.ClH/c1-2-6-21(32)29-14-13-18(15-29)31-24-22(23(26)27-16-28-24)30(25(31)33)17-9-11-20(12-10-17)34-19-7-4-3-5-8-19;/h3-5,7-12,16,18H,13-15H2,1H3,(H2,26,27,28);1H/t18-;/m1./s1
InChIKey UQYDCIJFACDXSG-GMUIIQOCSA-N
Smiles CC#CC(=O)N1CCC(C1)N2C3=NC=NC(=C3N(C2=O)C4=CC=C(C=C4)OC5=CC=CC=C5)N.Cl
Isomeric SMILES CC#CC(=O)N1CC[C@H](C1)N2C3=NC=NC(=C3N(C2=O)C4=CC=C(C=C4)OC5=CC=CC=C5)N.Cl
PubChem CID 71571562
Molecular Weight 490.94

Certificates(CoA,COO,BSE/TSE and Analysis Chart)

C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:

Chemical and Physical Properties

Sensitivity Moisture sensitive
DMSO(mg / mL) Max Solubility 98
DMSO(mM) Max Solubility 199.6170611
Water(mg / mL) Max Solubility <1
Molecular Weight 490.900 g/mol
XLogP3
Hydrogen Bond Donor Count 2
Hydrogen Bond Acceptor Count 6
Rotatable Bond Count 4
Exact Mass 490.152 Da
Monoisotopic Mass 490.152 Da
Topological Polar Surface Area 105.000 Ų
Heavy Atom Count 35
Formal Charge 0
Complexity 825.000
Isotope Atom Count 0
Defined Atom Stereocenter Count 1
Undefined Atom Stereocenter Count 0
Defined Bond Stereocenter Count 0
Undefined Bond Stereocenter Count 0
The total count of all stereochemical bonds 0
Covalently-Bonded Unit Count 2

Solution Calculators

Reviews

Customer Reviews

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.